Sanjaya Swain

About

Dr. Sanjaya Swain is a leading urologic oncologist whose research focuses on advancing minimally invasive surgical techniques for the treatment of bladder and upper tract cancers. He is best known for his pivotal contributions to the landmark RAZOR (Randomized Open versus Robotic Cystectomy) trial, which demonstrated that robotic radical cystectomy is noninferior to open surgery for progression-free survival. His 2019 analysis of the trial’s 3-year follow-up, cited over 115 times, provided crucial evidence on predictors of recurrence and long-term outcomes, establishing robotic cystectomy as a viable standard of care. Dr. Swain has also pioneered operative techniques for robotic-assisted laparoscopic nephroureterectomy and robotic partial nephrectomy using the da Vinci Xi system, publishing early experience and technical guides that have shaped modern surgical practice. His work on comparing complication and readmission rates between robotic and open cystectomy further underscores his commitment to improving patient safety and recovery. With a career dedicated to rigorous clinical trials and surgical innovation, Dr. Swain’s research has profoundly influenced the adoption of robotic surgery in urologic oncology, benefiting thousands of patients worldwide.

Research Focus

Key Achievements

Top Papers

1. 1
   Predictors of Recurrence, and Progression-Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup

   115 citations · 2019
2. 2
   Operative technique and early experience for robotic-assisted laparoscopic nephroureterectomy (RALNU) using da Vinci Xi

   38 citations · 2015
3. 3
   Robotic Partial Nephrectomy with the Da Vinci Xi

   22 citations · 2016
4. 4
   Comparison of Complication and Readmission Rates Between Robot-Assisted and Open Radical Cystectomy: Results From the Randomized RAZOR Clinical Trial

   5 citations · 2025

Key Collaborators

Contact & Links